TipRanks
Pharma Bio Services (PBSV)
OTHER OTC:PBSV
US Market
PBSV
Pharma Bio Services
RESEARCH TOOLSreports
Want to see PBSV full AI Analyst Report?

Pharma Bio Services (PBSV) Ratios

47 Followers

Pharma Bio Services Ratios

PBSV's free cash flow for Q3 2026 was $296.11. For the 2026 fiscal year, PBSV's free cash flow was decreased by $ and operating cash flow was $-0.03. See a summary of the company’s cash flow.
Ratios
TTM
Oct 25Oct 24Oct 23Oct 22
Liquidity Ratios
Current Ratio
 11.30 7.70 8.32 9.01 9.46
Quick Ratio
 11.30 7.70 8.32 9.01 9.46
Cash Ratio
 <0.01 1.94 3.59 4.85 6.86
Solvency Ratio
 -0.01 0.07 -0.23 0.40 0.26
Operating Cash Flow Ratio
 -0.31 -0.12 -0.30 0.88 0.28
Short-Term Operating Cash Flow Coverage
 0.00 0.00 0.00 0.00 0.00
Net Current Asset Value
$ 10.24B$ 11.65M$ 13.12M$ 15.63M$ 15.85M
Leverage Ratios
Debt-to-Assets Ratio
 0.00 <0.01 0.01 0.02 0.02
Debt-to-Equity Ratio
 0.00 <0.01 0.01 0.02 0.03
Debt-to-Capital Ratio
 0.00 <0.01 0.01 0.02 0.03
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 1.10 1.15 1.19 1.23 1.25
Debt Service Coverage Ratio
 0.00 0.00 0.00 0.00 0.00
Interest Coverage Ratio
 0.00 0.00 0.00 0.00 0.00
Debt to Market Cap
 0.00 0.00 0.00 0.00 0.00
Interest Debt Per Share
 0.00 <0.01 <0.01 0.02 0.02
Net Debt to EBITDA
 62.59 -24.85 5.94 -7.70 -11.40
Profitability Margins
Gross Profit Margin
7319.03%32.33%26.46%29.84%25.16%
EBIT Margin
-1.63%-1.05%-13.54%6.58%6.06%
EBITDA Margin
-0.26%1.50%-11.64%7.73%6.32%
Operating Profit Margin
-1.63%-7.08%-13.54%6.58%6.06%
Pretax Profit Margin
2.84%-1.05%-7.94%9.94%6.13%
Net Profit Margin
-147.13%-1.12%-8.18%7.72%5.19%
Continuous Operations Profit Margin
-147.13%-1.12%-8.18%7.72%5.19%
Net Income Per EBT
-5187.10%106.58%102.93%77.64%84.71%
EBT Per EBIT
-173.61%14.78%58.67%151.02%101.14%
Return on Assets (ROA)
-0.12%-0.74%-4.77%6.58%4.87%
Return on Equity (ROE)
-0.27%-0.84%-5.67%8.12%6.08%
Return on Capital Employed (ROCE)
>-0.01%-5.35%-8.94%6.30%6.34%
Return on Invested Capital (ROIC)
>-0.01%-5.34%-8.84%4.85%5.33%
Return on Tangible Assets
-0.12%-0.74%-4.77%6.58%4.87%
Earnings Yield
-148.60%-0.81%-5.84%6.71%5.09%
Efficiency Ratios
Receivables Turnover
 3.92 3.81 3.79 4.31 3.89
Payables Turnover
 1.77K 6.15 6.20 8.12 8.91
Inventory Turnover
 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
 0.12 61.89 25.85 43.61 33.66
Asset Turnover
 <0.01 0.66 0.58 0.85 0.94
Working Capital Turnover Ratio
 <0.01 0.71 0.61 0.97 1.02
Cash Conversion Cycle
 92.99 36.33 37.52 39.76 52.78
Days of Sales Outstanding
 93.20 95.73 96.38 84.73 93.75
Days of Inventory Outstanding
 0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
 0.21 59.39 58.86 44.97 40.97
Operating Cycle
 93.20 95.73 96.38 84.73 93.75
Cash Flow Ratios
Operating Cash Flow Per Share
 -13.30 >-0.01 -0.02 0.08 0.03
Free Cash Flow Per Share
 -13.30 >-0.01 -0.03 0.08 0.02
CapEx Per Share
 <0.01 <0.01 <0.01 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
 1.00 1.03 1.28 1.00 0.97
Dividend Paid and CapEx Coverage Ratio
 -88.48 -0.12 -0.30 1.09 0.17
Capital Expenditure Coverage Ratio
 -47.07K -32.34 -3.55 260.79 30.75
Operating Cash Flow Coverage Ratio
 0.00 -7.45 -2.92 5.46 1.22
Operating Cash Flow to Sales Ratio
 -32.11 -0.02 -0.06 0.11 0.03
Free Cash Flow Yield
-3243.26%-1.79%-5.45%9.65%2.90%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -1.14 -122.73 -17.13 14.90 19.65
Price-to-Sales (P/S) Ratio
 0.99 1.38 1.40 1.15 1.02
Price-to-Book (P/B) Ratio
 <0.01 1.04 0.97 1.21 1.19
Price-to-Free Cash Flow (P/FCF) Ratio
 -0.03 -55.94 -18.34 10.36 34.51
Price-to-Operating Cash Flow Ratio
 -0.03 -57.67 -23.50 10.32 33.39
Price-to-Earnings Growth (PEG) Ratio
 0.15 1.41 0.11 0.49 -0.13
Price-to-Fair Value
 <0.01 1.04 0.97 1.21 1.19
Enterprise Value Multiple
 -324.49 67.06 -6.10 7.18 4.74
Enterprise Value
 7.87M 9.04M 6.75M 9.42M 5.81M
EV to EBITDA
 -324.49 67.06 -6.10 7.18 4.74
EV to Sales
 0.83 1.00 0.71 0.55 0.30
EV to Free Cash Flow
 -0.03 -40.81 -9.29 5.00 10.13
EV to Operating Cash Flow
 -0.03 -42.07 -11.91 4.98 9.80
Tangible Book Value Per Share
 456.08 0.52 0.60 0.70 0.72
Shareholders’ Equity Per Share
 456.08 0.52 0.60 0.70 0.72
Tax and Other Ratios
Effective Tax Rate
 0.06 -0.07 -0.03 0.22 0.15
Revenue Per Share
 0.41 0.39 0.41 0.74 0.84
Net Income Per Share
 -0.61 >-0.01 -0.03 0.06 0.04
Tax Burden
 -51.87 1.07 1.03 0.78 0.85
Interest Burden
 -1.74 1.00 0.59 1.51 1.01
Research & Development to Revenue
 0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
 246.60 0.39 0.40 0.00 0.00
Stock-Based Compensation to Revenue
 1.82 <0.01 <0.01 <0.01 <0.01
Income Quality
 -1.39 2.14 0.73 1.44 0.59
Currency in USD